Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pullar

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|May 1, 1987
Effect of sulphasalazine on the radiological progression of rheumatoid arthritisT Pullar, J A Hunter, H A Capell
Annals of the Rheumatic Diseases|May 1, 1987
Sulphasalazine and hepatic transaminasesT Pullar, J A Hunter, H A Capell
Drugs|January 1, 1986
Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel diseaseH A Capell, T Pullar, J A Hunter
British Journal of Rheumatology|August 1, 1989
A study of tolerance to the psychomotor effects of indomethacin in healthy volunteersT Pullar, S Dale, J Lowe, et al.
Clinical Rheumatology|June 1, 1985
Second line therapy in rheumatoid arthritis--a four year prospective studyT Pullar, J A Hunter, H A Capell
Rheumatology and Rehabilitation|August 1, 1982
Gold and penicillamine therapy: is shared care with general practitioners effective and safe?T Pullar, J A Hunter, H A Capell
Annals of the Rheumatic Diseases|February 1, 1984
Does second-line therapy affect the radiological progression of rheumatoid arthritis?T Pullar, J A Hunter, H A Capell
Annals of the Rheumatic Diseases|December 1, 1985
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritisT Pullar, J A Hunter, H A Capell
British Medical Journal (Clinical Research Ed.)|May 25, 1985
Which component of sulphasalazine is active in rheumatoid arthritis?T Pullar, J A Hunter, H A Capell
Clinical Rheumatology|November 26, 2002
The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-upA W Al-Allaf, L Ottewell, T Pullar
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|May 1, 1987
Effect of sulphasalazine on the radiological progression of rheumatoid arthritisT Pullar, J A Hunter, H A Capell
Annals of the Rheumatic Diseases|May 1, 1987
Sulphasalazine and hepatic transaminasesT Pullar, J A Hunter, H A Capell
Drugs|January 1, 1986
Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel diseaseH A Capell, T Pullar, J A Hunter
British Journal of Rheumatology|August 1, 1989
A study of tolerance to the psychomotor effects of indomethacin in healthy volunteersT Pullar, S Dale, J Lowe, et al.
Clinical Rheumatology|June 1, 1985
Second line therapy in rheumatoid arthritis--a four year prospective studyT Pullar, J A Hunter, H A Capell
Rheumatology and Rehabilitation|August 1, 1982
Gold and penicillamine therapy: is shared care with general practitioners effective and safe?T Pullar, J A Hunter, H A Capell
Annals of the Rheumatic Diseases|February 1, 1984
Does second-line therapy affect the radiological progression of rheumatoid arthritis?T Pullar, J A Hunter, H A Capell
Annals of the Rheumatic Diseases|December 1, 1985
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritisT Pullar, J A Hunter, H A Capell
British Medical Journal (Clinical Research Ed.)|May 25, 1985
Which component of sulphasalazine is active in rheumatoid arthritis?T Pullar, J A Hunter, H A Capell
Clinical Rheumatology|November 26, 2002
The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-upA W Al-Allaf, L Ottewell, T Pullar
Pageof 9